The estriol use in the perioperative period by patients with genital prolapse

Author:

Khashukoeva A. Z.1ORCID,Nosova L. A.1ORCID,Dmitrashko T. E.2ORCID,Beslangurova Z. A.3ORCID,Lyafisheva D. M.4ORCID,Shokulova Z. Kh.1ORCID

Affiliation:

1. Pirogov Russian National Research Medical University

2. Pirogov Russian National Research Medical University; Russian Clinical and Research Center of Gerontology

3. Maikop State Technological University

4. Medical Center “My Doctor”

Abstract

Introduction. Postmenopausal women in a state of oestrogen deficiency often experience pelvic prolapse with underlying genitourinary menopausal syndrome, when the progression of atrophic processes in the vaginal mucosa comes to the forefront.Aim. To evaluate the results of the use of topical hormonal therapy in the perioperative period to improve the vaginal epithelial surface appearance in postmenopausal women who need surgical treatment of pelvic prolapse.Materials and methods. A comparative prospective randomized clinical trial included 60 postmenopausal patients aged 60 to 69 years with a postmenopausal period of 10 to 20 years, suffering from POP-Q stage II–IV pelvic prolapse (ICS, 1996). All patients were recommended surgical treatment using vaginal approach. The treatment group (Group 1) included 30 patients who received topical hormonal therapy with an estriol drug (Ovestin cream, 1 mg/g) within 1 month before reconstructive plastic surgery. The comparison group (Group 2) included 30 patients who did not receive hormonal treatment in the perioperative period.Results. No complications were observed in the treatment group after reconstructive plastic surgery in the early and late postoperative periods. In the comparison group, natural urination was not achieved in 9 of 30 (35.0%) women on Day 2 after surgery, in 4 of 30 (13.3%) patients on Day 3. Also in that group, 4 of 30 (13.3%) patients experienced infectious and inflammatory complications in the postoperative period, the mucous membrane healing in 5/30 (16.6%) patients took a long time, over 1 month.Conclusions. The use of topical hormonal therapy with an estriol drug in the perioperative period in patients who require surgical treatment of pelvic prolapse results in the relief of vulvovaginal atrophy symptoms and adequate regeneration of the vaginal mucosa, which helps reduce the likelihood of complications in both early and late postoperative periods. 

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference46 articles.

1. Gorodnova N.V., Samarskaya N.A. Improving the quality of life of the population in the current economic conditions of Russia. Diskussiya. 2019;(3):48–58. (In Russ.) https://doi.org/10.24411/2077-7639-2019-10031.

2. Makatsariya A.D., Blinov D.V., Bitsadze V.O., Khizroeva J.K. Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018. Obstetrics, Gynecology and Reproduction. 2019;(3):227–238. (In Russ.) https://doi.org/10.17749/2313-7347.2019.13.3.227-238.

3. Usoltseva E.N., Ionova T.I. Quality of life peculiarities in women during postmenopause period. Bulletin of the Multinational Centеr of Quality of Life Research. 2019;(33–34):55–67. (In Russ.) Available at: https://iaget.ru/wp-content/uploads/2022/02/%D0%B6%D0%B5%D0%BD%D1%89%D0%B8%D0%BD-%D0%B2-%D0%BF%D0%BE%D1%81-.pdf.

4. Gasparyan S.A., Vasilenko I.A., Papikova K.A., Drosova L.D. Menopause: up the stairs leading down. Meditsinskiy Sovet. 2020;(13):76–83. (In Russ.) https://doi.org/10.21518/2079-701X-2020-13-76-83.

5. Kozlov P.V., Dobrokhotova Yu.Eh., Ilina I.Yu. Modern approaches to drug correction of genitourinary menopausal syndrome. Lechebnoe Delo. 2021;(2):58–62. (In Russ.) https://doi.org/10.24412/2071-5315-2021-12331.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3